Comprehensive Stool Analysis: Which Tests to Order Alongside

What a Comprehensive Stool Analysis Actually Measures

A comprehensive stool analysis is not a single test. It is a panel of 20 to 40 individual assays run on one or more stool samples, covering five broad domains: microbial ecology, digestive capacity, intestinal inflammation, metabolic byproducts, and immune markers.

PCR-based platforms such as the GI-MAP (Diagnostic Solutions Laboratory) and the Genova CDSA 2.0 have replaced older culture-based methods as the standard approach because quantitative PCR detects organisms present at fewer than 100 colony-forming units per gram of stool, a threshold culture misses entirely. A 2019 systematic review in Gut Microbes found that PCR-based stool panels identified clinically relevant pathogens in 23% more samples than paired culture methods [1].

The Five Analyte Domains

Microbial ecology. Bacteria (commensals, opportunists, pathogens), fungi (Candida spp., Saccharomyces), parasites, and viruses are quantified by DNA copy number. Dysbiosis is flagged when keystone species such as Lactobacillus spp. Or Bifidobacterium spp. Fall below the 25th percentile reference range while opportunists such as Klebsiella pneumoniae or Citrobacter freundii are elevated.

Digestive capacity. Fecal elastase-1 reflects pancreatic exocrine output. A value <100 µg/g stool indicates severe exocrine pancreatic insufficiency (EPI) and correlates with fat malabsorption; a value between 100 and 200 µg/g is borderline. Steatocrit or fat globules on microscopy can confirm fat malabsorption when elastase-1 is low [2].

Intestinal inflammation. Calprotectin is a calcium-binding protein released by neutrophils. Values <50 µg/g are generally considered normal; values above 250 µg/g have a pooled sensitivity of 93% and specificity of 96% for active IBD in a 2019 Cochrane review of 19 studies (N=2,499) [3].

Metabolic byproducts. Short-chain fatty acids (SCFAs: butyrate, propionate, acetate) reflect fermentation efficiency. Low butyrate is associated with colonocyte energy deficit and increased mucosal permeability [4].

Immune markers. Secretory IgA (sIgA) in stool reflects mucosal immune competence. Chronically low sIgA (<510 µg/mL on many reference ranges) suggests impaired first-line gut defense and recurrent microbial overgrowth [5].

Why Ordering the Stool Panel Alone Leaves Gaps

The stool analysis answers what is living in the colon and how inflamed it is. It does not directly measure small-intestinal bacterial overgrowth proximal to the ileocecal valve, systemic inflammatory burden, intestinal tight-junction integrity at the protein level, or hepatic detoxification load driven by microbial metabolites. Each gap requires a specific paired test.

Think of it this way: a complete metabolic panel tells you serum glucose but not insulin resistance. The stool panel tells you microbial counts but not whether those microbes have already breached the gut wall.

Paired Test 1: Serum Zonulin (Intestinal Permeability)

What It Adds

Zonulin is the only known physiological regulator of intercellular tight junctions in the gut. When elevated in serum, it signals that tight-junction proteins (occludin, claudin-1) are disassembling, allowing bacterial lipopolysaccharide (LPS) to enter portal circulation. A 2020 meta-analysis in Nutrients (12 studies, N=1,109) found serum zonulin was significantly higher in patients with IBS, IBD, and non-alcoholic fatty liver disease compared to healthy controls [6].

How to Order It

Serum zonulin is drawn fasting. Most commercial labs report a reference range of <22 ng/mL. Values between 22 and 40 ng/mL suggest moderate permeability; above 40 ng/mL warrants aggressive dietary and supplement intervention. Lactulose/mannitol urine ratio is a functional complement to zonulin: a ratio above 0.025 independently confirms permeability even when zonulin is borderline [7].

Clinical Pairing Logic

Order zonulin whenever the stool panel shows elevated beta-glucuronidase (above 400 nmol/min/g), reduced sIgA, or elevated LPS-producing organisms. These findings together build a coherent picture of a leaky-gut phenotype that zonulin alone cannot establish.

Paired Test 2: SIBO Breath Testing (Lactulose or Glucose)

Why the Stool Panel Cannot Diagnose SIBO

The small intestine contains <10^4 organisms per mL of luminal fluid in healthy adults. The stool panel samples colonic content, where concentrations are 10^11 organisms per gram. Small-intestinal overgrowth is therefore invisible to stool DNA analysis. A positive lactulose breath test showing a hydrogen rise of >20 ppm above baseline within 90 minutes has a specificity of 89% for jejunal bacterial overgrowth based on a 2017 ACG Clinical Guideline [8].

Glucose vs. Lactulose

Glucose is absorbed in the proximal small intestine, so a positive glucose breath test (hydrogen rise >12 ppm above baseline) confirms proximal SIBO with high specificity (approximately 83%) but misses mid-to-distal SIBO. Lactulose reaches the colon intact in most patients and can show a double-peak pattern suggesting both small-intestinal and colonic fermentation. The ACG guideline recommends glucose breath testing as the preferred non-invasive SIBO screen [8].

Methane-Dominant Patterns

Methane-producing archaea (Methanobrevibacter smithii) are identified on some stool PCR panels. A methane-dominant breath test result (methane >10 ppm at any point during lactulose testing) correlates strongly with intestinal methanogen overgrowth (IMO) and constipation-predominant IBS. The combination of elevated M. Smithii on the stool panel plus a positive methane breath test justifies a rifaximin/neomycin dual antibiotic protocol rather than rifaximin alone [9].

Paired Test 3: Fecal Calprotectin (Standalone Inflammation Marker)

Many comprehensive stool panels include calprotectin, but some functional panels omit it in favor of other inflammatory markers. If the specific panel ordered does not include calprotectin, adding it as a standalone test is non-negotiable before attributing symptoms to functional dysbiosis rather than structural IBD.

The 2021 ACG Clinical Guideline on IBS states: "We suggest that clinicians use fecal calprotectin to exclude IBD in patients who present with IBS-type symptoms." A threshold of 50 µg/g carries a negative predictive value of 97% for active Crohn's disease [10]. Any stool panel result showing elevated inflammatory markers (lysozyme, lactoferrin, or calprotectin if included) with a calprotectin above 250 µg/g should prompt gastroenterology referral for colonoscopy before initiating gut-restoration protocols.

Paired Test 4: Urinary Organic Acids (Microbial Metabolite Load)

What Organic Acids Reveal

Urinary organic acids (OAT panel) capture downstream metabolites of microbial fermentation that appear in urine, not stool. Arabinose, tartaric acid, and citramalic acid are yeast-derived. Elevated HPHPA (3-hydroxyphenylpropionic acid) signals Clostridia overgrowth in the small intestine and has been associated with neurological symptoms including brain fog and mood dysregulation in several small observational studies [11].

The Stool-OAT Correlation

A stool panel showing Candida albicans above the 95th percentile reference, combined with elevated urinary arabinose on the OAT, provides convergent evidence of systemic yeast burden that stool DNA alone cannot quantify systemically. Great Plains Laboratory (now Mosaic Diagnostics) published internal validation data showing that 78% of patients with OAT arabinose above 50 mmol/mol creatinine had concurrent positive stool yeast cultures [12].

Ordering Protocol

First morning void urine, no antifungals or high-sugar foods for 48 hours prior. Most functional medicine labs offer combined stool-plus-OAT ordering at a reduced panel price.

Paired Test 5: Serum and Stool Inflammatory Markers (CRP, ESR, Lactoferrin)

High-sensitivity CRP (hs-CRP) and erythrocyte sedimentation rate (ESR) are inexpensive serum tests that contextualize intestinal inflammation systemically. An hs-CRP above 3 mg/L alongside elevated fecal calprotectin shifts the differential away from functional dysbiosis toward structural IBD or systemic autoimmunity [13].

Fecal lactoferrin, an iron-binding glycoprotein released by activated neutrophils, correlates with calprotectin but uses a different antibody-based ELISA methodology. Studies comparing the two markers in patients with Crohn's disease showed lactoferrin sensitivity of 78% vs. Calprotectin sensitivity of 93% at a calprotectin cutoff of 50 µg/g, making calprotectin the preferred single inflammatory stool marker [3].

Paired Test 6: CBC with Differential and Iron Studies

Dysbiosis and leaky gut can cause subclinical iron deficiency through two mechanisms: impaired duodenal iron absorption from villous inflammation and blood loss from mucosal erosions. A CBC with differential showing a mean corpuscular volume (MCV) <80 fL with low serum ferritin (<30 ng/mL) adds an objective marker of malabsorption that supports the stool panel findings [14].

Eosinophilia on the differential (absolute eosinophil count >500 cells/µL) raises the prior probability of parasitic infection or eosinophilic gastroenteritis, both of which the stool PCR panel screens for but which require histologic confirmation.

Paired Test 7: Food Sensitivity IgG Panel (Adjunctive, Lower Evidence Grade)

IgG-based food sensitivity panels remain controversial. The British Dietetic Association's 2022 position paper states that IgG antibodies to foods reflect exposure, not allergy or intolerance, and are not diagnostic of any condition [15]. Despite this, some functional practitioners order IgG panels alongside stool analysis on the premise that gut-permeability-driven antigen translocation produces measurable IgG responses.

The evidence base for IgG-guided dietary elimination is limited. One randomized controlled trial (N=150, Atkinson 2004 in Gut) found a 10% greater reduction in IBS symptom severity scores with IgG-guided elimination compared to sham diet over 12 weeks [16]. Order this test only after ruling out structural pathology and only as a hypothesis-generating tool, not a diagnostic one.

Interpreting the Combined Panel: A Practical Framework

The table below maps stool-panel finding combinations to the most appropriate paired tests and clinical actions. This framework was developed by the HealthRX medical team based on published guideline thresholds and functional medicine clinical consensus.

| Stool Panel Finding | Primary Paired Test | Secondary Paired Test | Clinical Action Threshold | |---|---|---|---| | Calprotectin >250 µg/g | Serum hs-CRP, ESR | Colonoscopy referral | Immediate GI referral | | Elastase-1 <100 µg/g | 72-hour fecal fat | Serum lipase, amylase | Consider pancreatic enzyme replacement | | sIgA <510 µg/mL | Serum total IgA | Salivary cortisol/DHEA | Evaluate adrenal and immune axis | | Elevated opportunists, low butyrate | Zonulin (serum) | OAT panel | Begin prebiotic/probiotic protocol | | Methane-producing archaea elevated | Lactulose breath test | Glucose breath test | Rifaximin 550 mg + neomycin 500 mg protocol | | Candida spp. >95th percentile | OAT (arabinose) | Serum beta-glucan | Antifungal + low-sugar diet intervention | | Parasites detected (PCR positive) | CBC with differential | Serology (IgG/IgM) | Antiparasitic treatment per identified species | | H. Pylori elevated | Urea breath test confirmation | Serum gastrin | Triple therapy per ACG H. Pylori guideline |

Normal Reference Ranges and What Abnormal Looks Like

Reference ranges vary by laboratory platform. These values represent the most commonly cited thresholds across Genova Diagnostics, Doctor's Data, and Diagnostic Solutions Laboratory reference materials.

Microbial Markers

• Lactobacillus spp.: optimal range 4.0 to 8.7 log10 cells/g. Values <3.5 log10 suggest significant dysbiosis.
• Bifidobacterium spp.: optimal range 5.0 to 9.0 log10 cells/g.
• H. Pylori (PCR): detected/not detected. Any detection is clinically significant given H. Pylori's WHO Group I carcinogen status [17].
• Blastocystis hominis: mildly elevated in 20 to 30% of asymptomatic adults; clinical significance is debated, but counts above 10^6 copies/g warrant treatment in symptomatic patients.

Digestive Markers

• Fecal elastase-1: normal >200 µg/g; borderline 100 to 200 µg/g; severe EPI <100 µg/g [2].
• Steatocrit: normal <2%; above 5% confirms fat malabsorption.
• Beta-glucuronidase: normal 0 to 400 nmol/min/g; elevated activity increases estrogen recirculation and hepatic detox burden.

Inflammatory Markers

• Calprotectin: normal <50 µg/g; mildly elevated 50 to 200 µg/g; significantly elevated >200 µg/g; IBD-range above 250 µg/g [3].
• Fecal lactoferrin: normal <7.25 µg/mL (Doctor's Data reference).
• sIgA: normal 510 to 2,040 µg/mL; below 510 indicates mucosal immune suppression.

How to Lower Elevated Inflammatory and Dysbiosis Markers

Elevated calprotectin above 200 µg/g, high beta-glucuronidase, or reduced butyrate-producing bacteria each require distinct interventions.

Reduce calprotectin: Identify and treat the root cause. In IBD, mesalazine (4.8 g/day) reduced calprotectin by 60% at 8 weeks in a 2018 randomized trial (N=210) [18]. In functional dysbiosis without structural disease, a low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet for 6 weeks reduced calprotectin by 28% in IBS patients in a 2017 Gut trial (N=104) [19].

Raise butyrate: Supplementing with tributyrin (sodium butyrate 600 mg twice daily) or increasing dietary resistant starch (green banana flour, cooked-and-cooled potatoes) raises fecal butyrate concentration. A 12-week RCT (N=66) found sodium butyrate supplementation increased fecal butyrate by 34% and reduced dysbiosis scores on 16S sequencing [20].

Raise secretory IgA: Colostrum supplementation (2.0 g/day) raised salivary and fecal sIgA by 33% over 8 weeks in a double-blind RCT (N=80) [21]. Reducing psychological stress (the cortisol-sIgA inverse relationship is well-documented) and addressing adrenal dysfunction are equally important.

How to Raise Low Fecal Elastase-1

Fecal elastase-1 cannot be raised by diet alone when exocrine pancreatic insufficiency is the cause. Pancreatic enzyme replacement therapy (PERT), specifically pancrelipase (Creon 36,000 lipase units per meal, 18,000 per snack), is the standard of care per the 2020 AGA guideline on EPI [22]. In patients with borderline elastase-1 (100 to 200 µg/g) without confirmed pancreatic pathology, zinc supplementation (30 mg elemental zinc daily) and magnesium repletion may improve pancreatic acinar cell function, though evidence remains preliminary.

Timing, Sample Collection, and Pre-Test Preparation

Stool sample quality directly affects result accuracy. Specific preparation steps reduce false positives and false negatives.

• Stop probiotics 5 to 7 days before collection.
• Stop antibiotics 4 weeks before collection (minimum); some labs recommend 8 weeks.
• Stop antifungals 14 days before collection.
• Avoid colonoscopy prep solutions within 30 days of testing.
• Collect samples in the morning when possible; refrigerate immediately and ship with provided cold packs within 24 hours.

For PCR-based panels, a single sample is sufficient for most analytes. Parasite detection accuracy improves with two samples collected on non-consecutive days, per CDC guidance on ova and parasite exams [23].